Pro-inflammatory CXCL-10, TNF-α, IL-1β, and IL-6: biomarkers of SARS-CoV-2 infection
Anuradha S. Tripathy(ICMR-National Institute of Virology), Priya Abraham(ICMR-National Institute of Virology), Yogesh K. Gurav(ICMR-National Institute of Virology), Nitin D. Mokashi, Varsha Potdar(ICMR-National Institute of Virology), Manohar Lal Choudhary(ICMR-National Institute of Virology), Prakash Sarje(ICMR-National Institute of Virology), Himanshu Kaushal(ICMR-National Institute of Virology), Varsha Dange, Siddhesh Vishwakarma(ICMR-National Institute of Virology), Diptee Trimbake(ICMR-National Institute of Virology), Bipin Tilekar(ICMR-National Institute of Virology), Sudhir Patsute
Cited by 71
Related Papers
SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India
|Microorganisms|2021|658
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial
|The Lancet|2021|361
Convergent evolution of SARS-CoV-2 spike mutations, L452R, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India
|bioRxiv (Cold Spring Harbor Laboratory)|2021|268
Full-genome sequences of the first two SARS-CoV-2 viruses from India
|The Indian Journal of Medical Research|2020|174